Advertisement

13 Responses

  1. StephenS
    StephenS August 7, 2014 at 7:37 am | | Reply

    I’m also interested in knowing why JDRF has decided to keep the interim title for at least a year. Doesn’t this leave people (volunteers, donors, and employees) unsure about the future? I can’t imagine a corporate entity leaving the CEO position potentially open for so long. Hope I’m misinterpreting this.

    1. AmyT
      AmyT August 7, 2014 at 5:19 pm | | Reply

      Actually, interim CEOs for that period are not rare at all in private industry. The idea is that organizations want to take ample time to select a leader who’ll be right for the long-term.

  2. Nicole
    Nicole August 7, 2014 at 8:22 am | | Reply

    Wow, what political answers. He almost never answers the actual questions asked. I have to say I am very much concerned with the direction the JDRF is going.

    1. David
      David August 7, 2014 at 2:18 pm | | Reply

      I wonder if this interview was conducted by e-mail because his responses really do seem to have been written by a publicist.

      Oh, and his statement that, “What people think about Monsanto as a company is irrelevant in this context,” is both incorrect and slightly rude. His professional background is entirely relevant to his suitability to run the JDRF.

      1. Scott E
        Scott E August 10, 2014 at 4:35 pm | | Reply

        I would agree with David’s comment that this seems to be conducted by email. Otherwise, I would have expected a follow-up question rather than an editor’s note that says the question wasn’t really answered.

        With that said, Mr. Rapp seems more like a hard-nosed businessman while Mr. Brewer was a likeable face and front-man for the organization. The strategy seems to remain the same, so the reason for the change must have to do with the mannerism and execution of the leadership. Is it warranted or justified? Having not seen the behind-the-scenes activities, I really don’t know. I can only speculate.

        I do find it a bit patronizing and insulting to imply that he (or anyone, for that matter) is qualified to lead the organization simply because of his family relationships to people with T1D. That may demonstrate commitment, but not capability. Quite frankly, I would expect that level of commitment regardless of who was appointed to the post. When it comes to capability, the only reassurance we got was that his earlier credentials are “irrelevant.” I wish he’d told us some of his own ideas rather than repeating the company line.

    2. Brian
      Brian August 28, 2014 at 6:44 pm | | Reply

      Nicole a lot of people are and I have been concern since day one when I learn about the organization when my daughter was diagnosed 3 years ago. They change their tagline way to much and have no clear direction.

  3. Cure News: Week 8/7 | The Juvenile Diabetes Cure Alliance Blog

    [...] DiabetesMine released an interview with Derek Rapp, the newly appointed head of the JDRF. And what he says is…interesting, to say the least. We [...]

  4. Denise
    Denise August 7, 2014 at 7:25 pm | | Reply

    Here’s a question for one of the next interviews with anyone at a high level at JDRF. JDRF has only financially supported the non-glucagon artificial pancreas projects in the past 4-5 years. Why hasn’t the JDRF financially supported the Bionic Pancreas project (ie the glucagon-containing dual-hormone initiative)?? Seeing Derek’s answers within this interview, I have a feeling as to what type of answer will come…”At JDRF, we’re hit-up for hundreds funding requests each year, and we have to strategize, formulate, and prioritize which projects receive our funding, and unfortunately that means that JDRF can’t fund all projects requested of us and tough decisions must be made.” That’s where I think that the interviewers need to start putting them on the hot seat a bit more and press for more concrete answers. Because in doing so, it will start forcing them them think about how they’re going to be called to task for critical decisions they make.
    Another great question would be, “Why does JDRF only give X% to practical cure research when studies point to the fact that XX% of donors want their funds to go towards practical cure funding?”
    The JDRF is doing great things, but when donors start feeling like they could be doing more or taking more cured-based approaches, if there truly are good reasons why they’re not, those donors deserve the transparency as to why and not answers filled with fluff.

  5. John
    John August 13, 2014 at 5:19 pm | | Reply

    To say your work experience is irrelevant is ignorant. The JDRF is a lost cause, showing little progress in moving funded research from the safety of the lab (mice) to human trials. Humans are the ultimate test and since the JDRF wants to limit its failures, stay where you are safe, playing with mice. Too many failures and funding will really dry up.

    I have no confidence in the JDRF because they are more concerned with academia results than bedside results. Rapp must be getting ready for a payday with comments like we have to pay to attract top people.

    There is a real lack of honesty with just how far away a cure really is. Probably several decades.

    1. stella
      stella August 20, 2014 at 10:04 am | | Reply

      Just an FYI to anyone saying that JDRF isn’t making progress or looking at different cure or treatment approaches.

      “Aug 19, 2014, ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of VC-01™ Candidate Cell Replacement Therapy for Type 1 Diabetes…
      Instrumental in our ability to achieve this milestone are JDRF, the leading global organization focused on type 1 diabetes (T1D) research.”

      http://www.marketwatch.com/story/viacyte-inc-announces-fda-acceptance-of-ind-to-commence-clinical-trial-of-vc-01-candidate-cell-replacement-therapy-for-type-1-diabetes-2014-08-19

  6. Brian
    Brian August 28, 2014 at 6:35 pm | | Reply

    Here is another good one for everyone. I have research a lot of other cure related organizations. Some of which give 100% of donations to their cure causes. Want to know what they have in common? Leadership at the very top who are use to running cure NON-profits. People with health and medical backgrounds. So far not one with a CEO with a corporate background. Some one mention Viacyte as something the JDRF did. I will give the JDRF credit for supporting this work, but I wonder if this technology would be here now if as much money was given to this life changing technology as was given to the AP.

  7. John Fitzgerald McIntyre
    John Fitzgerald McIntyre November 25, 2014 at 3:49 am | | Reply

    Thank you for referrring to a post on our Facebook page:

    It is utterly unacceptable that JDRF includes this Monsanto linkage. Educate yourself about Monsanto, PCB’s and the way that corporations manage their social accountability (in this case… for the rise in diabetes). It is totally unacceptable that ONE out of THREE people will develop some kind of disabetes in the near future. And it is clear that JDRF in its prevention program does NOTHING to research the rise in diabetes as a result of environmental stress factors (we still remember Anniston)

    Another Interview:
    More: http://www.doxing.eu/jdrf/2014/05/23/j-f-mcintyre-full-interview/

    ^ Enough explanation and references in there to make you question the integrity of Derek Rapp.

    IT IS NOT ACCEPTABLE THAT MONSANTO MANAGES ITS ACCOUNTABILITY FOR THE RISE IN DIABETES BY CONTROLKING DIABETES RESEARCH IN WHATEVER WAY.

    DEREK RAPP HAS TO LEAVE JDRF .. ASAP!

    Kind regards,
    John F. Fitzgerald

Leave a Reply